skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Medical device vigilance systems: India, US, UK, and Australia

Perspectives

(2245) Views  (775) Full article downloads

Authors: Pooja Gupta, Manthan D Janodia, Puralea C Jagadish, et al

Published Date November 2010 Volume 2010:3 Pages 67 - 79
DOI: http://dx.doi.org/10.2147/MDER.S12396

Pooja Gupta, Manthan D Janodia, Puralea C Jagadish, Nayanabhirama Udupa
Manipal Collge of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India

Abstract: The term medical device includes a wide category of products ranging from therapeutic medical devices exerting their effects locally such as tissue cutting, wound covering or propping open clogged arteries, to highly sophisticated computerized medical equipment and diagnostic medical devices. To achieve uniformity among the national medical device regulatory systems and increase the access to safe, effective, and clinically beneficial medical technologies, the Global Harmonization Task Force (GHTF) was conceived in 1992 by five members: European Union, United States, Australia, Japan, and Canada. All regulated countries have clearly defined medical devices, as has the GHTF. Although GHTF has tried to achieve harmonization with respect to medical devices, some differences still exist in the national laws of the countries of GHTF. Further, regulated countries have classified medical devices on the basis of their associated risk. In the Indian regulatory system, medical devices are still considered as drugs. In 2006, the Medical Device Regulation Bill was recommended to consolidate laws for medical devices and to establish the Medical Device Regulatory Authority of India. In addition, medical devices are not classified by any Indian regulatory authority. Although India has moved towards harmonizing its medical device regulations with those of regulated countries, this study aims to identify whether India should have a vigilance system in harmony with those of GHTF or develop its own system for medical devices.

Keywords: medical device, vigilance, regulatory systems, GHTF, India






Readers of this article also read:

30-days mortality in patients with perforated peptic ulcer: A national audit
Medical complications in patients with stroke: data validity in a stroke registry and a hospital discharge registry
Medical databases in studies of drug teratogenicity: methodological issues
Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank
National Stroke Audit: The Australian experience
Identification of a reliable subset of process indicators for clinical audit in stroke care: an example from Australia
Bryan total disc arthroplasty: a replacement disc for cervical disc disease
An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen®
Everolimus-eluting coronary stents
New stent design for use in small coronary arteries during percutaneous coronary intervention
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University